Clinical Trials on Mild to Moderate Dementia

Total 1187 results

Oneness Biotech Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Mild to Moderate COVID-19

Taiwan, United States
HK inno.N Corporation

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients

Mild to Moderate Atopic Dermatitis
Shanghai Vinnerna Biosciences Co., Ltd.
Sponsor GmbH

Completed

JT001 (VV116) for the Treatment of COVID-19

Mild to Moderate COVID-19

China
Guangdong Raynovent Biotech Co., Ltd

Completed

Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19

Mild to Moderate COVID-19

China
Greenpharma S.A.S.
Complife Italia S.r.l

Completed

A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Italy
HanAll BioPharma Co., Ltd.

Completed

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

United States
Bayer

Completed

A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Germany
Eisai Inc.
Pfizer

Completed

The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

Mild to Severe Alzheimer's Disease

United States
Takeda

Terminated

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

Mild Cognitive Impairment Due to Alzheimer's Disease

United States, Australia, United Kingdom, Switzerland
KoBioLabs
Novotech (Australia) Pty Limited

Completed

Study of Multiple Ascending Dose of KBL693 in Healthy Participants

Moderate to Severe Asthma

Australia
Abbott

Completed

Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain

Moderate to Severe Chronic, Non-malignant Pain

United States
Frontier Biotechnologies Inc.

Recruiting

Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19

Mild to Moderate COVID-19

China
Northern Illinois University
University Autonoma de Santo Domingo

Terminated

Treatment of Depression Using a Mobile Application in the Dominican Republic

Depression Moderate | Depression Mild

United States, Dominican Republic
Cytos Biotechnology AG

Completed

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Mild Essential Hypertension | Moderate Essential Hypertension

Switzerland
Fundación Pública Andaluza para la Investigación...
Îngrijiri la domiciliu, Romania; Consiglio Nazionale delle Ricerche, Italy; Institut... and other collaborators

Completed

TV-based Service to Support People Living With Mild Dementia or Mild Cognitive Impariment (TV-AssistDem)

Mild Cognitive Impairment | Mild Dementia

Spain, Romania
Mundipharma Research GmbH & Co KG

Completed

A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain

Subjects With Moderate to Severe, Chronic Nonmalignant Pain
MindAhead UG
University Medical Center Göttingen

Recruiting

Efficacy of MindAhead's Digital Behavioral Activation Therapy in Adults With MCI or Mild Dementia

Mild Cognitive Impairment | Mild Dementia

Germany
Federal Research Center of Fundamental and Translational...

Completed

Real-time fMRI Neurofeedback for Mild/Moderate Depression

Depression Moderate | Depression Mild

Russian Federation
Deepsonbio

Recruiting

The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia

Dementia, Mild | Cognitive Disorder Mild

Korea, Republic of
Hong Kong Metropolitan University
Chinese University of Hong Kong; The British Council in Hong Kong

Completed

Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial

Mild Cognitive Impairment | Dementia Mild

Hong Kong
Hong Kong Metropolitan University
Chinese University of Hong Kong; Food and Health Bureau, Hong Kong

Completed

An Advance Care Planning Programme for Persons With Early Stage Dementia in the Community

Mild Cognitive Impairment | Dementia Mild

Hong Kong
Instituto Nacional de Ciencias Medicas y Nutricion...
Actipulse Neuroscience

Terminated

Effect of High Frequency/Low Intensity Transcranial Magnetic Stimulation in Cognitive Traits of an Elderly Population of Subjects With Mild Cognitive Impairment and Mild Dementia.

Mild Cognitive Impairment | Mild Dementia

Mexico
Johan Sanmartin Berglund
Andaluz Health Service; Universidad Politecnica de Madrid; Anglia Ruskin University and other collaborators

Unknown

Support Monitoring and Reminder Technology (SMART4MD)

Mild Dementia | Cognitive Impairment, Mild

Belgium, Czechia, Spain, Sweden
Massachusetts General Hospital
National Institutes of Health (NIH); National Institute on Aging (NIA)

Recruiting

Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and Emotions

Dementia | Dementia Alzheimers | Caregiver Stress Syndrome | Caregiver Burnout | Dementia, Mild | Dementia Moderate | Dementia Severe | Dementia Frontotemporal

United States
Actavis Inc.

Completed

Clinical Endpoint Study of Ivermectin 1% Cream

Moderate to Severe Papulopustular Rosacea

United States
Mead Johnson Nutrition

Withdrawn

Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based (AA) Formulas

Cow's Milk Allergy | Intolerance to Extensively Hydrolyzed Formulas | Intolerance to Breast Milk

United Kingdom
University of California, San Francisco

Not yet recruiting

Treating Major Depression With Yoga Mono-therapy

Depression Moderate | Depression Mild

United States
University of Bern

Completed

Factorial Trial Investigating Outcome and Adherence Relevant Factors in an Online Self-help Intervention for Depression (HERMES)

Depression Moderate | Depression Mild

Switzerland
Gazi University

Completed

Cognitive Behavioral Therapy-Based Group Counseling (CBTBGC)

Depression Moderate | Depression Mild

Turkey
International Centre for Diarrhoeal Disease Research...

Completed

Feasible Means to Address Moderately Malnourished Children Within BINP Communities

Mild and Moderate Malnourished Children
Alexandria University
Assoc. Prof. Ayman Ibrahim Baess; Dr. Noha Alaa Eldine Hassan Hamdy; Ph. Hanya...

Recruiting

Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease

Mild-to-moderate COVID-19

Egypt
Aristotle University Of Thessaloniki
National and Kapodistrian University of Athens; University of Ulm; Greek Alzheimer...

Completed

Combined Cognitive and Physical Exercises Through Computer Games in Elderly: The LLM Project (LLM)

Healthy | Mild Cognitive Impairment | Mild Dementia
Douglas Mental Health University Institute
Johns Hopkins University; McGill University

Completed

Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia

Alzheimer Disease | Cognitive Decline Due to Alzheimer Disease | Mild Cognitive Impairment Due to Alzheimer Disease

Canada
Edwards Lifesciences

Terminated

Hypotension Prediction Index (HPI) SMART-BP Trial

Moderate to High-risk Noncardiac Surgery

United States
Shanghai Junshi Bioscience Co., Ltd.

Completed

Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

Moderate to Severe Psoriasis

China
Bristol-Myers Squibb

Terminated

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Psoriasis, Moderate to Severe

United States
NovoBliss Research Pvt Ltd
Collagen Lifesciences Private Limited

Completed

A Proof of Science, Dose-Response Study to Evaluate the Safety, Efficacy of Different Dosages of Test Treatments

Healthy | Osteoarthritis, Knee | Brittle Nails | Mild to Moderate Acne | Stiffness of Joint, Nec, Involving Ankle and Foot in MDR24_1 | Other Specified Diseases of Hair and Hair Follicles

India
Eurofarma Laboratorios S.A.

Completed

A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)

Mild to Moderate Persistent Allergic Rhinitis

Brazil
University of Zurich
Waid City Hospital, Zurich

Completed

Move for Your Mind - Pilot Trial (MFYM - P)

Mild Cognitive Impairment | Mild Dementia | Fall Prevention

Switzerland
Ain Shams University

Completed

A Newly Modified Technique for Levator Muscle Tucking in Blepharoptosis Surgery: An Egyptian Tertiary Center Study (Lidtucking)

Mild Ptosis | Moderate Ptosis

Egypt
University Hospital, Rouen
Centre Hospitalier Intercommunal Elbeuf-Louviers / Val de Reuil

Unknown

Identify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases and Their Primary Caregivers (CAREGIVERSPRO)

Cognitive Impairment, Mild | Dementia, Mild

France
National Taiwan University Hospital

Unknown

Dementia Patient's Behavior Evaluation Using Noninvasive Ambient Sensor

Mild Cognitive Impairment, Dementia

Taiwan
Ki Woong Kim
Ministry of Health & Welfare, Korea

Completed

Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia

Mild Cognitive Impairment | Dementia, Mild

Korea, Republic of
Wake Forest University Health Sciences

Completed

Biologics Anchoring Study

Moderate-to-severe Psoriasis

United States
Bristol-Myers Squibb
Nitto Denko Corporation

Completed

Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)

Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4)

Bulgaria, United States
Merck KGaA, Darmstadt, Germany

Completed

CLEAR Study: Clinical Experience Acquired With Raptiva Study

Moderate to Severe Psoriasis

Switzerland
Merck KGaA, Darmstadt, Germany

Completed

Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

Moderate to Severe Psoriasis

Switzerland
Pfizer

Completed

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

Moderate to Severe Psoriasis

Korea, Republic of
GC Cell Corporation

Recruiting

Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis

Moderate to Severe Plaque Psoriasis

Korea, Republic of
UCB Biopharma SRL

Active, not recruiting

A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis (BE CONNECTED)

Moderate to Severe Plaque Psoriasis

United States, Canada, Germany, Poland

Clinical Trials on Mild to Moderate Dementia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations